Biotech startups VCs just backed
Get it by email
Companies like these go out in the next weekday's email. One-click unsubscribe.
$1M · galy.co
GALY Co. — Cocoa and cotton grown from cells for brands
GALY grows cocoa and cotton from cells using biological processes, supplying brands with traceable, scalable ingredients without traditional farming.
Information technologyBiotechnology$1M+
$100M Series C · delixtherapeutics.com
Delix Therapeutics — Non-hallucinogenic psychedelic drugs for mental health
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
BiotechnologyData and analyticsHealthcareSV Health neurodegen fundStrategic Pharma$100M+ · +1 · +4
$4.7M Seed · getpeppermint.ai
Peppermint — Billing and collections for clinical trial sites
Peppermint is a software company based in San Francisco that focuses on AI-powered financial operations for clinical research teams. It aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials. Founded in 2026, the company provides a platform that automates billing, invoicing, and collections. This platform integrates with existing clinical trial management systems to streamline revenue cycle management.
BiotechnologySoftwareHealthcareEvan MooreBenjamin MannNight Capital · +8 · +11
$16.4M · vescent.com
Vescent Technologies — Frequency combs, lasers and controls for quantum tech
Vescent is leading and enabling the commercialization of Quantum Technologies in the lab and in the field. It has been providing frequency Combs, Lasers, and Controls to 100s of customers on the front lines of scaling the commercial quantum ecosystem throughout the world with low-SWaP, ruggedness, and IP.
ManufacturingBiotechnology$10M+
$75M · happysleep.com
Happy Health — Smart ring that diagnoses sleep apnea at home
Happy Health is a Texas-based digital health company developing a physician-guided platform for continuous home healthcare. The company has created an FDA-cleared smart ring that diagnoses obstructive sleep apnea in as few as three nights using clinical-grade sensors and AI-powered physiological modeling. By collecting over 2.8 million biometric measurements nightly, Happy Health's platform builds individualized physiological baselines to detect disease earlier and shift care delivery from hospitals to homes. The platform aims to eventually support detection and management across cardiovascular, metabolic, and other chronic diseases.
BiotechnologyHealthcareArtificial intelligenceArch Venture PartnersOpenLoop$50M+ · +1 · +4
$8.5M · 28bio.com
28bio — Brain organoids that predict which therapies work in humans
28bio was formerly known as AxoSim, Inc. 28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today's neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition.
BiotechnologyHealthcareArtificial intelligence$1M+Machine learning · +2
Biotech startups VCs just backed, by email.
Get it by email
Companies like these go out in the next weekday's email. One-click unsubscribe.
$45M Series A · coherenceneuro.com
Coherence Neuro — Implants and wearables that monitor and treat cancer
Coherence Neuro is a developer of AI-powered oncology medical devices. The company focuses on creating specialized implantable or wearable bioelectronic devices that monitor and treat cancer by analyzing live human biological data. Their efforts aim to advance chronic human clinical trials and seek FDA breakthrough device designation. Coherence Neuro is led by CEO Ben Woodington and CTO Dr. Elise Jenkins.
BiotechnologyHealthcareArtificial intelligenceLux Capital8VCTimeless · +20 · +23
$251M Series D · varda.com
Varda Space Industries — Reentry capsules for in-orbit pharmaceutical processing
Varda Space Industries is making reentry as common as launch. We are building the infrastructure for a thriving orbital economy and enabling foundational science, from in-orbit pharmaceutical processing to reliable and economical hypersonic reentry capsules.
OtherManufacturingInformation technologyAlso CapitalGiant Step8090 Industries · +8 · +11
$75M Series C · bighatbio.com
BigHat Biosciences — AI platform for designing antibody therapeutics
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Biotechnology$50M+
$75M · solcoaindustries.com
Solcoa Industries — Rare earth metals from halide-free chemistry
Solcoa Industries is a rare earth metals producer based in Alameda, CA. Founded in 2025, the company develops halide-free chemistries, engineers processes, and builds and operates its own modular reactors. Solcoa's innovative processes are designed to produce zero harmful emissions including toxic fluoride gases. The company currently produces samarium and neodymium-praseodymium (NdPr) metal and is constructing a new plant in Nevada.
ManufacturingBiotechnology$50M+
$20M Series A · mithrl.com
Mithrl — AI built on biomedical world models for drug discovery
Mithrl is an AI infrastructure company focused on the biopharma sector. It develops advanced platforms that utilize proprietary biomedical world models to optimize AI technologies. The company aims to enhance drug discovery and development through sophisticated AI-driven solutions.
BiotechnologyArtificial intelligenceMachine learningAgi HouseHeadlineObvious Ventures · +1 · +4
$50M Series A · nuancelabs.ai
Nuance Labs — Full-duplex audiovisual foundation model for conversation
Nuance Labs is a Seattle AI research lab building a full-duplex audiovisual foundation model for human conversation. Instead of chaining transcription, a language model, voice synthesis and animation together, a single unified system perceives and generates speech, facial expression and body language at the same time — so it reads the non-verbal cues in a live conversation and responds in the moment rather than after the turn ends. Founded by former Apple PhD researchers Fangchang Ma (CEO), Edward Zhang (CTO) and Karren Yang (Chief Scientist), with Yaser Sheikh advising. Target uses are sales, customer service, coaching, professional training and education, with a research preview due later in 2026. The $50M Series A was led by returning investor Lightspeed Venture Partners, with Accel and South Park Commons also returning and NVIDIA and Define Ventures joining.
BiotechnologyArtificial intelligenceMachine learningDefine VenturesNvidiaSouth Park Commons · +4 · +7
YC F26 · superradiant.co
SuperRadiant — Robots that form hypotheses and run scientific experiments
SuperRadiant builds Embodied Scientific Intelligence: general-purpose robotic experimentalists that observe, form hypotheses and run experiments in the physical world. The system automates the full experimental loop while staying flexible enough for real discovery work, adapting to changing protocols and new instruments. Founded in 2026 in San Francisco by Cooper Niu, Benedict Quartey and Owen Tower, with a team drawn from Brown, NASA JPL, Fermilab and CERN. Y Combinator Fall 2026.
RoboticsEnergyAdvanced materialsYCArtificial intelligenceBiotechnology · +1 · +4
YC F26 · halmoslabs.com
Halmos Labs — Software that picks the most informative lab experiments
Halmos Labs builds autonomous systems for scientific research: intelligent experimental design software that works out which experiment would reduce uncertainty most, so labs get more information from fewer experiments and fewer experiments per conclusion. The platform runs parallel analyses under many possible assumptions, validates every analysis, and answers open-ended questions about results where fixed workflows fall short, with early work spanning wet-lab experiment design and cancer vaccine manufacturing. Founded in 2026 in Lund, Sweden by Mattias Akke and Linus von Ekensteen Lofgren, who have worked at MIT, AstraZeneca and Danske Bank. Part of Y Combinator's Fall 2026 batch.
AI powered drug discoverySwarm AIBiotechnologyYCHealthcare · +2
$74M · odysseyenergysolutions.com
Odyssey Energy Solutions — Connects solar companies with financiers to fund projects
Odyssey’s mission is to radically accelerate capital deployment into distributed energy to get more projects built, faster. Odyssey brings together solar companies and financiers through a technology platform to streamline solar financing through every phase of the process, from origination and due diligence to credit underwriting, procurement, portfolio tracking, and asset management, reporting & compliance.
EnergyTriple JumpCygnum CapitalBiotechnologyBritish International InvestmentTransition Ventures · +10 · +13
$250M Series B · instinct.co
Instinct — AI assistant you text and call to organize your life
Instinct is an AI assistant built to organize your life: users connect their apps and devices and talk to it by text message and phone call. Founded by Noah Shinn and operated by Spear Street Technology, it went viral while still in private beta — and drew scrutiny over the breadth of app permissions it asks for. The $250M round, led by Index Ventures and Benchmark, values the company at $2.5B and takes total funding to $350M.
BiotechnologyHealthcareBenchmarkIndex Ventures$100M+ · +2
YC S26 · spectreintelligence.ai
Spectre Intelligence — Trading firm that trains AI traders instead of hiring humans
Spectre Intelligence is a multi-strategy trading firm that trains AI traders instead of hiring human ones. An independent research and trading company built around reasoning under uncertainty, it currently trades in the semiconductor and biotechnology sectors. Founded by Michelle Li (CEO) and Joshua Zyzak, the firm is based in San Francisco and is part of Y Combinator's Summer 2026 batch.
BiotechnologyInvestingTradingYCSemiconductorsFintech · +3
$27.4M · checkerspot.com
Checkerspot — Nutritional fats and oils hard to source from nature
Checkerspot is a pioneering biotechnology company and Certified B Corporation™ that develops high value triglyceride fats and oils not easily or sustainably sourced from nature, at commercially relevant scale & cost, providing market-ready ingredients critical to meeting our nutritional needs at every phase of life.
OtherBiotechnology$10M+
YC S26 · neuromorphic.vision
Neuromorphic — Robot brains that work across any robot body
Building embodiment agnostic robot brains.
Artificial intelligenceHard techRoboticsYCB2BBiotechnology · +1 · +4
$68.4M · integratedbio.com
Integrated Biosciences — Small-molecule drugs for age-related diseases
Integrated Biosciences is a biotechnology company specializing in synthetic biology and machine learning to develop advanced therapeutics for age-related diseases. Founded in 2022, the company focuses on innovative drug discovery methods, utilizing AI and synthetic biology to increase efficiency in drug development. Its cutting-edge approach allows for the identification and modulation of biological pathways, alongside the discovery of novel small-molecule drug candidates. The company's mission is to achieve healthier human aging through scientific advancements.
BiotechnologyArtificial intelligenceTherapeutics$50M+Machine learning · +2
$3.5M Seed · claryx.com
Claryx — Genomic outbreak detection for hospital infection teams
Claryx is a genomic intelligence company focused on preventing hospital outbreaks. It is developing an immune system for hospitals that detects transmission in real-time and guides intervention by infection prevention teams. The company was founded by brothers Kurt and Dirk Hackenberger.
BiotechnologyHealthcareHealth diagnosticsOutlander VC$1M+ · +2
$25M · excedr.com
Excedr — Leases lab equipment to life sciences companies
Excedr, Inc. is a scientific equipment leasing company founded in 2011, providing operating lease solutions and ongoing support for critical laboratory instrumentation. It serves various life sciences segments including therapeutics, diagnostics, and contract research organizations. The company's distinctive approach combines scientific expertise and flexible financing, enabling customers to preserve capital while accessing essential equipment.
BiotechnologyGlobal Single Family OfficesExisting InvestorsBok Financial$10M+ · +2

YC S26 · gutgutgoose.com
Gutgutgoose — AI training infrastructure via custom probiotics
AI training infrastructure via custom probiotics
BiotechnologyPersonalizationHealth wellnessHealthcareYCYC S26 · +3
YC S26 · illumelabs.ai
Illume Labs — A 24/7 personal health and longevity companion
24/7 Personal Health & Longevity Companion
Generative AIHealthcareBiotechnologyHealth wellnessArtificial intelligenceYC · +1 · +4